Plerion is the new flavoured, chewable and easy to give dog wormer. Plerion worm tablets are efficacious and broad spectrum, they are a tasty soft chewable and thus easy to give. Plerion Dog worming tablets are manufactured in two sizes, Plerion 5 for smaller dogs and Plerion 10 for dogs over 10Kg body weight.

Plerion 5 chewable tablets are brown, slightly speckled and oblong in shape, containing 25 mg pyrantel (as embonate), 100 mg oxantel (as embonate) and 25 mg praziquantel. Each Plerion 10 chewable tablets are brown, slightly speckled and round in shape, contains 50 mg pyrantel (as embonate), 200 mg oxantel (as embonate), 50 mg praziquantel.

Plerion is used in the treatment of dogs harbouring mixed parasitic infestations with the following adult stages of nematode and cestode species, Toxocara canis, Toxascaris leonina, Uncinaria stenocephala, Ancylostoma caninum, Trichuris vulpis, Dipylidium caninum, Taenia ovis, Taenia pisiformis, Taenia hydatigena, Taenia multiceps, Echinococcus spp.

Give as a single dose rate of 5 mg pyrantel + 20 mg oxantel + 5 mg praziquantel per kg bodyweight, i.e. 1 Plerion 5 tablet per 5 kg b.w., or 1 Plerion 10 tablet per 10 kg b.w. Each chewable tablets contain a flavour and are taken voluntarily by most dogs. The tablets can be given directly to the dog or with food.

Do not use in dogs younger than 2 months of age, for Plerion 5 tablets, do not use in dogs weighing less than 2.5 kg and for Plerion 10 tablets, do not use in dogs weighing less than 5 kg. Do not use in animals with known hypersensitivity to any of the components of the product. On rare occasions vomiting and diarrhoea may be observed following the treatment. Although not observed in studies performed with this product, anorexia may occur as it is a common adverse effect of products containing praziquantel.

In some animals, Ancylostoma caninum and Toxocara canis may not be totally eradicated by the treatment, resulting in a continued risk of shedding of eggs into the environment. Follow-up examinations of the faeces are advisable and, based on the results of these examinations, treatment with a nematodicidal product should be carried out, if necessary. The safety of the product has not been established in bitches during pregnancy and lactation. Do not use simultaneously with levamisole, piperazine or choline esterase inhibitors.